De Novo Design of a TROP-2-Targeting Peptide PET Tracer via AI-Guided Binding Interface Mimicry
Bioconjugate Chemistry · 2026
DOI: 10.1021/acs.bioconjchem.6c00394 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioconjugate Chemistry, 2026. Verfasst von Zefang Lin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine the First Affiliated Hospital, Fujian Medical University, Fuzhou350005, China. Hauptthemen laut MEDLINE: Antigens, Neoplasm, Cell Adhesion Molecules, Peptides, Positron Emission Tomography Computed Tomography. Die Arbeit nennt 37 Literaturangaben. Gefördert von: High Innovation Plan, National Natural Science Foundation of China (NSFC), Joint Funds for the Innovation of Science and Technology, Fujian Province.
Abstract (Originalsprache)
Trophoblast cell surface antigen 2 (TROP-2) is a transmembrane glycoprotein overexpressed across a range of epithelial malignancies, yet its clinical assessment still relies largely on invasive immunohistochemical analysis of biopsied tissues. In this study, we employed the PepMimic artificial intelligence platform to de novo design a TROP-2-targeting peptide, TR23, via binding interface mimicry, which was subsequently conjugated with DOTA and radiolabeled with 68Ga to yield the peptide-based PET probe [68Ga]Ga-DOTA-TR23. The tracer bound TROP-2 with nanomolar affinity (KD = 26.8 nM), showed selective cellular uptake in TROP-2-positive cells, and exhibited high radiochemical purity (>95%) with excellent stability in saline and serum. Micro-PET/CT imaging in pancreatic (BxPC-3), prostate (PC3), and thyroid (BCPAP) xenograft models revealed rapid, specific tumor accumulation with high contrast and low background uptake, while competitive blocking studies with excess unlabeled TR23 substantially suppressed tumor uptake, confirming receptor-mediated specificity. Quantitative analysis further demonstrated strong positive correlations between SUVmax and TROP-2 expression levels verified by immunohistochemistry across all three tumor types. Collectively, these findings establish [68Ga]Ga-DOTA-TR23 as a promising peptide-based PET tracer for rapid, specific, and quantitative imaging of TROP-2-positive tumors, and highlight the PepMimic-enabled strategy as a versatile platform for peptide-based probe discovery, supporting the translational potential of this tracer as a pan-cancer diagnostic agent for precision molecular imaging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine the First Affiliated Hospital, Fujian Medical University, Fuzhou350005, China.
- Department of Nuclear Medicine National Regional Medical Center Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou350212, China.
- Department of Nuclear Medicine Provincial Clinical Key Specialty of Fujian, Fuzhou350212, China.
- Key Laboratory of Organ Regeneration and Reconstruction Institute of Zoology, Chinese Academy of Sciences, Beijing100101, China.
- School of Medicine, Shihezi University, Shihezi832003, China.
- Fujian Key Laboratory of Precision Medicine for Cancer the First Affiliated Hospital, Fujian Medical University, Fuzhou350005, China.
ORCID-Profile: Zihua Wang
Förderung
- High Innovation Plan
- National Natural Science Foundation of China (NSFC)
- Joint Funds for the Innovation of Science and Technology, Fujian Province
- Beijing Natural Science Foundation
- Natural Science Foundation of Fujian Province
Zitieren
APA
Lin, Z., Yang, Z., Ma, S., Lin, X., Zhang, Q., Miao, W., & Wang, Z. (2026). De Novo Design of a TROP-2-Targeting Peptide PET Tracer via AI-Guided Binding Interface Mimicry. Bioconjugate Chemistry. https://doi.org/10.1021/acs.bioconjchem.6c00394
Vancouver
Lin Z, Yang Z, Ma S, Lin X, Zhang Q, Miao W, et al. De Novo Design of a TROP-2-Targeting Peptide PET Tracer via AI-Guided Binding Interface Mimicry. Bioconjugate Chemistry. 2026. doi:10.1021/acs.bioconjchem.6c00394
BibTeX
@article{Lin2026,
author = {Lin, Zefang and Yang, Zhimin and Ma, Sen and Lin, Xiuting and Zhang, Qiang and Miao, Weibing and Wang, Zihua},
title = {De Novo Design of a TROP-2-Targeting Peptide PET Tracer via AI-Guided Binding Interface Mimicry},
journal = {Bioconjugate Chemistry},
year = {2026},
doi = {10.1021/acs.bioconjchem.6c00394}
}
EUVIMED